RICC A/S: Financial statements 2021
CVR: 20690003
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
RICC A/S (CVR 20690003) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 133,722,000 and a net result of DKK 4,549,000 compared with DKK -155,848,000 the year before. That is a decrease of 51.2% compared with the year before. Equity in the 2021 report amounted to DKK -4,883,000. The company had 70 employees in the financial year.
- Gross Profit
- DKK 133,722,000
- Profit/Loss
- DKK 4,549,000
- Equity
- DKK -4,883,000
- Total Assets
- DKK 68,827,000
- Employees
- 70
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 133.7 mio. | 4.5 mio. | -4.9 mio. | 70 |
| 2020 | - | 274.3 mio. | -155.8 mio. | -6 mio. | 63 |
| 2019 | - | 141.4 mio. | 45.9 mio. | 209.8 mio. | 65 |
| 2018 | 198.6 mio. | 159.3 mio. | 914 t. | 107 mio. | 74 |
| 2017 | - | 175.8 mio. | 38.3 mio. | 156.1 mio. | 71 |
Official annual report
Find more companies like RICC A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 1, 2021, Darine Ghanem has joined the board of directors of RICC A/S.
As of September 30, 2021, Richard John Wright has left the board of directors of RICC A/S.
As of September 1, 2021, Darine Ghanem is registered as adm. dir. of RICC A/S.
As of August 31, 2021, Richard John Wright has stepped down as director of RICC A/S.
RICC A/S has published its annual report for 2020. Gross profit came to DKK 274,294,000, and the net result was DKK -155,848,000.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.